One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Regulatory and Informational Gaps in the Over-the-Counter Eye Care Product Industry—Over the Counter, Under the Radar
David N. Younessi, BA1; John C. Lin, ScB2; Timothy M. Janetos, MD, MBA1
doi : 10.1001/jamaophthalmol.2023.4961
December 2023, Vol 141, No. 12, Pages 1100-1178
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency
Kamran Abbasi1; Parveen Ali2; Virginia Barbour3; Thomas Benfield4; Kirsten Bibbins-Domingo5; Stephen Hancocks6; Richard Horton7; Laurie Laybourn-Langton8; Robert Mash9; Peush Sahni10; Wadeia Mohammad Sharief11; Paul Yonga12; Chris Zielinski13
Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion
Karen M. Wai, MD1; Austen Knapp, MD1; Cassie A. Ludwig, MD, MS1; Euna Koo, MD1; Ravi Parikh, MD, MPH2,3; Ehsan Rahimy, MD1,4; Prithvi Mruthyunjaya, MD, MHS1
Machine Learning Models for Predicting Long-Term Visual Acuity in Highly Myopic Eyes
Yining Wang, MD1; Ran Du, MD, PhD1,2; Shiqi Xie, MD, PhD1; Changyu Chen, MD1; Hongshuang Lu, MD1; Jianping Xiong, MD1; Daniel S. W. Ting, MD, PhD3,4; Kengo Uramoto, MD1; Koju Kamoi, MD, PhD1; Kyoko Ohno-Matsui, MD, PhD1
Neurodevelopmental Outcomes in Infants Screened for Retinopathy of Prematurity
Reem Karmouta, BS1; Jason C. Strawbridge, MD1; Seth Langston, MD2; Marie Altendahl, MD3; Monica Khitri, MD1; Alison Chu, MD3; Irena Tsui, MD1
Incidence and Risk Factors for Neutropenia After Intra-Arterial Chemotherapy for Retinoblastoma
Debora H. Lee, MD1; Richard Donkor, OD, PhD2; Matthew N. Parvus, BS2; Mark J. Dannenbaum, MD3; Amy C. Schefler, MD1,2
Pathogen Surveillance for Acute Infectious Conjunctivitis
Edmund Tsui, MD1,2; Ruti Sella, MD3,4; Vivien Tham, MD5,6; Alan W. Kong, MD2; Esmeralda McClean, OD7; Lee Goren, MD3; Irit Bahar, MD3,4; Nina Cherian, BS1,2; Joana Ramirez, BS1,2; Reginald E. Hughes Jr, BS1,2; Joseph K. Privratsky, BS1,2; Tania Onclinx, MD2; Rachel Feit-Leichman, MD2; Angel Cheng, BS5; Iliana Molina, DHA, MBA7; Phillip Kim, OD7; Carol Yu, OD7; Kevin Ruder, BS8; Alexander Tan5; Cindi Chen, MS8; YuHeng Liu, BA8; Thomas Abraham, BS8; Armin Hinterwirth, PhD8; Lina Zhong, BS8; Travis C. Porco, PhD, MPH8,9; Thomas M. Lietman, MD8,9; Gerami D. Seitzman, MD8,9; Thuy Doan, MD, PhD8,9; for the SCORPIO Study Group
Psychiatric Comorbidities Associated With Keratoconus
Margarita Safir, MD1,2,3; Idan Hecht, MD1,2; Dan Heller, MD3,4; Eran Pras, MD1,2; Michal Lifshitz, MD3,4; Adi Einan-Lifshitz, MD1,2
Efficacy and Safety of Brolucizumab for Diabetic Macular Edema
Rishi P. Singh, MD1; Mark R. Barakat, MD2,3; Michael S. Ip, MD4; Charles C. Wykoff, MD, PhD5; David A. Eichenbaum, MD6,7; Sunir Joshi, MD8; David Warrow, MD9; Veeral S. Sheth, MD10; Jana Stefanickova, MD, PhD11; Yong Soo Kim, MD12; Fanyin He, PhD13; Ga Eun Cho, MD14; Yuhua Wang, MD12; Andrés Emanuelli, MD15,16
Social Determinants of Health and Perceived Barriers to Care in Diabetic Retinopathy Screening
Rohith Ravindranath, MS1; Isaac A. Bernstein, BS1; Karen S. Fernandez, BS1; Cassie A. Ludwig, MD, MS1; Sophia Y. Wang, MD, MS1
Fever and Neutropenia Can Be a Risk to the Child’s Life
Ann M. Leahey, MD1; Carol L. Shields, MD2
Do Not Think of a Purple Wolf—Keratoconus, ADHD, and Itch
Maria A. Woodward, MD, MSc1,2; Emily L. Vogt, BA2
Intraocular Pressure in Eyes With Retinal Vein Occlusion Compared With Fellow Eyes
Ahmad A. Aref, MD1; Ingrid U. Scott, MD, MPH2,3; Neal L. Oden, PhD4; Michael S. Ip, MD5; Paul C. VanVeldhuisen, PhD4; Barbara A. Blodi, MD6; for the SCORE and SCORE2 Study Investigator Groups
Large Language Model Advanced Data Analysis Abuse to Create a Fake Data Set in Medical Research
Andrea Taloni, MD1; Vincenzo Scorcia, MD1; Giuseppe Giannaccare, MD, PhD1,2
Dematiaceous Fungal Keratitis With Tentacles Mimicking Pythium Keratitis
Rekha Sravya, MS1; Smriti Gaur, MS1; Naveen Radhakrishnan, MS1,2
Four-Year Follow-Up of a Pigmented Vitreous Cyst
Chengcheng Zhu, MD, PhD1; Changhui Liu, MS1; Jing Wang, MS1
Bilateral Acute Iris Transillumination After Systemic Moxifloxacin Treatment
Hannah W. Ng, MBChB, BMedSc(Hons)1
Iris Neovascularization After Vitreous Metastasis of a Cutaneous Melanoma
Gaia Leone, MD1,2; Marco Nassisi, MD1,2; Francesco Viola, MD1,2
Risk of New Retinal Vascular Occlusion After Messenger RNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data
Alan Y. Hsu, MD1; Chun-Ju Lin, MD2,3,4; James Cheng-Chung Wei, MD5,6,7
Risk of New Retinal Vascular Occlusion After Messenger RNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data
Po-Jui Chu, MD1; Ting-Han Tai, MD2; Tzu-Hsuan Fan, MD3
Risk of New Retinal Vascular Occlusion After Messenger RNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data
Ying-Cheng Chen, MD1,2; Chin-Cheng Chen, MD3,4; James Cheng-Chung Wei, MD, PhD5,6,7 Ying-Cheng Chen, MD1,2; Chin-Cheng Chen, MD3,4; James Cheng-Chung Wei, MD, PhD5,6,7
Risk of New Retinal Vascular Occlusion After Messenger RNA COVID-19 Vaccination Within Aggregated Electronic Health Record Data—Reply
Jacqueline K. Shaia, MS1,2; Priya Shukla, BS2,3; Rishi P. Singh, MD2,4
